One-two punch knocks out aggressive breast cancer cells
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.
Nano-sized ‘factories’ churn out proteins
Tiny particles could manufacture cancer drugs at tumor sites.
Targeted nanoparticles show success in clinical trials
Tiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.
Freeing radicals from their negative connotations
Killian Award recipient JoAnne Stubbe says some free radicals can be good for you.
Koch Institute, Dana-Farber/Harvard Cancer Center announce launch of 'Bridge Project' to attack most-lethal forms of cancer
Institutions, research teams, non-profit organizations join forces in novel approaches targeting pancreatic cancer, glioblastoma.
Delivering RNA with tiny sponge-like spheres
New RNA interference method holds promise for treating cancer, other diseases.
A faster way to catch cells
New microfluidic device could be used to diagnose and monitor cancer and other diseases.
Toying with biological systems
By swapping microbial genes, Chris Voigt designs cells with novel functions.
Metabolic errors can spell doom for DNA
New study could explain why variant enzymes boost the risk of cancer for some people.
Seeing what’s inside a tumor
Imaging technology could help researchers test new drugs for treating brain cancer.
How cancer cells get by on a starvation diet
New study shows that tumor cells, deprived of glucose, alter their metabolism to use other sources of sustenance.
Seeing cancer in three dimensions
Scientists find that the 3-D structure of a cancer cell’s chromosomes plays a big role in which genes get deleted or copied.
MIT senior Stephanie Lin wins Rhodes Scholarship
Student in biology, applied international studies will study at Oxford next year.
Living cells say: Can you hear me now?
Researchers find that cells’ chemical signaling includes a way to tell whether signals are being received or not.